Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Goldenberg

Showing results (41-50 of 318) with videos related to

Pageof 32
Sort By:
PPAR Research|September 10, 2008
Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer typesJack D Burton, David M Goldenberg, Rosalyn D Blumenthal
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 26, 2014
Al¹⁸F Labeling of Affibody MoleculesWilliam J McBride, David M Goldenberg, Robert M Sharkey
EJNMMI Research|May 9, 2013
Radiofluorination using aluminum-fluoride (Al18F)William J McBride, Robert M Sharkey, David M Goldenberg
Expert Opinion on Biological Therapy|April 6, 2016
Prospects and progress of antibody-drug conjugates in solid tumor therapiesSerengulam V Govindan, Robert M Sharkey, David M Goldenberg
Blood|February 3, 2009
A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapyRobert M Sharkey, Oliver W Press, David M Goldenberg
Cancer Research|October 6, 2005
Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen)Rosalyn D Blumenthal, Hans J Hansen, David M Goldenberg
Mabs|March 16, 2013
Monoclonal antibodies targeting CD20Chien-Hsing Chang, Edmund A Rossi, David M Goldenberg
Cancer Research|November 25, 2003
Meeting report on the Ninth Conference on Cancer Therapy with Antibodies and ImmunoconjugatesRobert M Sharkey, Edward A Sausville, David M Goldenberg
Molecular Cancer Therapeutics|March 1, 2006
Sphingolipid targets in cancer therapyDavid E Modrak, David V Gold, David M Goldenberg
Plos One|May 21, 2014
Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of LupusEdmund A Rossi, Chien-Hsing Chang, David M Goldenberg
Pageof 32

Showing results (41-50 of 318) with videos related to

Sort By:
Pageof 32
PPAR Research|September 10, 2008
Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer typesJack D Burton, David M Goldenberg, Rosalyn D Blumenthal
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 26, 2014
Al¹⁸F Labeling of Affibody MoleculesWilliam J McBride, David M Goldenberg, Robert M Sharkey
EJNMMI Research|May 9, 2013
Radiofluorination using aluminum-fluoride (Al18F)William J McBride, Robert M Sharkey, David M Goldenberg
Expert Opinion on Biological Therapy|April 6, 2016
Prospects and progress of antibody-drug conjugates in solid tumor therapiesSerengulam V Govindan, Robert M Sharkey, David M Goldenberg
Blood|February 3, 2009
A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapyRobert M Sharkey, Oliver W Press, David M Goldenberg
Cancer Research|October 6, 2005
Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen)Rosalyn D Blumenthal, Hans J Hansen, David M Goldenberg
Mabs|March 16, 2013
Monoclonal antibodies targeting CD20Chien-Hsing Chang, Edmund A Rossi, David M Goldenberg
Cancer Research|November 25, 2003
Meeting report on the Ninth Conference on Cancer Therapy with Antibodies and ImmunoconjugatesRobert M Sharkey, Edward A Sausville, David M Goldenberg
Molecular Cancer Therapeutics|March 1, 2006
Sphingolipid targets in cancer therapyDavid E Modrak, David V Gold, David M Goldenberg
Plos One|May 21, 2014
Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of LupusEdmund A Rossi, Chien-Hsing Chang, David M Goldenberg
Pageof 32